Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

North American clinical trials with LiquiVent to be reinitiated

Sep. 1, 1997

P&U cephem derivatives for inhibiting HLE

Aug. 29, 1997

FDA approves Hi-Tech's generic promethazine/codeine syrup

Aug. 28, 1997

Hoechst Marion Roussel reports new antiallergy agents

Aug. 25, 1997

New antiallergy agents described by Dainippon Ink

Aug. 20, 1997

Tachykinin antagonist with potential as antiasthmatic

Aug. 19, 1997

Cortecs announces phase II results for Pseudostat in chronic bronchitis

Aug. 14, 1997

FDA approves IND for cystic fibrosis drug

Aug. 13, 1997

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

First European clinical trials of pranlukast reported

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...